MedTrace Logo

Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis

NCT07153809 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-04

No results posted yet for this study

Summary

This study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT in patients with moderate to severe acute pancreatitis.

Conditions

Interventions

PROCEDURE

FMT

FMT bacterial solution will be injected through a nasojejunal nutrition tube once a day for five days.

PROCEDURE

Placebo

Physiological saline placebo will be injected through a nasojejunal nutrition tube once a day for five days.

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-12
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07153809 on ClinicalTrials.gov